CureVac NV
NASDAQ:CVAC

Watchlist Manager

CureVac NV

NASDAQ:CVAC

Watchlist

Dividends

Price: 4.48 USD 1.59%

Market Cap: 1B USD

Have any thoughts about
CureVac NV?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication
US	Chevron Corp NYSE:CVX	Energy

Add Price Alert

Price Target:

Last Price: 4.48 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching false

Delete

Cancel

CVAC Alert

CureVac NV

4.48

+0.07 (+1.59%)

52 Week Range	2.49 4.7
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US
	Chevron Corp NYSE:CVX	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

CureVac NV

What unique competitive advantages
does CureVac NV hold over its rivals?

What risks and challenges
does CureVac NV face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of CureVac NV.

What unique competitive advantages
does CureVac NV hold over its rivals?

What risks and challenges
does CureVac NV face in the near future?

Summarize the latest earnings call
of CureVac NV.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for CureVac NV.

Provide P/S
for CureVac NV.

Provide P/E
for CureVac NV.

Provide P/OCF
for CureVac NV.

Provide P/FCFE
for CureVac NV.

Provide P/B
for CureVac NV.

Provide EV/S
for CureVac NV.

Provide EV/GP
for CureVac NV.

Provide EV/EBITDA
for CureVac NV.

Provide EV/EBIT
for CureVac NV.

Provide EV/OCF
for CureVac NV.

Provide EV/FCFF
for CureVac NV.

Provide EV/IC
for CureVac NV.

Show me price targets
for CureVac NV made by professional analysts.

What are the Revenue projections
for CureVac NV?

How accurate were the past Revenue estimates
for CureVac NV?

What are the Net Income projections
for CureVac NV?

How accurate were the past Net Income estimates
for CureVac NV?

What are the EPS projections
for CureVac NV?

How accurate were the past EPS estimates
for CureVac NV?

What are the EBIT projections
for CureVac NV?

How accurate were the past EBIT estimates
for CureVac NV?

Compare the revenue forecasts
for CureVac NV with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of CureVac NV and its key competitors using the latest financial data.

Compare historical revenue growth rates
of CureVac NV against its competitors.

Analyze the profit margins
(gross, operating, and net) of CureVac NV compared to its peers.

Compare the P/E ratios
of CureVac NV against its peers.

Discuss the investment returns and shareholder value creation
comparing CureVac NV with its peers.

Analyze the financial leverage
of CureVac NV compared to its main competitors.

Show all profitability ratios
for CureVac NV.

Provide ROE
for CureVac NV.

Provide ROA
for CureVac NV.

Provide ROIC
for CureVac NV.

Provide ROCE
for CureVac NV.

Provide Gross Margin
for CureVac NV.

Provide Operating Margin
for CureVac NV.

Provide Net Margin
for CureVac NV.

Provide FCF Margin
for CureVac NV.

Show all solvency ratios
for CureVac NV.

Provide D/E Ratio
for CureVac NV.

Provide D/A Ratio
for CureVac NV.

Provide Interest Coverage Ratio
for CureVac NV.

Provide Altman Z-Score Ratio
for CureVac NV.

Provide Quick Ratio
for CureVac NV.

Provide Current Ratio
for CureVac NV.

Provide Cash Ratio
for CureVac NV.

What is the historical Revenue growth
over the last 5 years for CureVac NV?

What is the historical Net Income growth
over the last 5 years for CureVac NV?

What is the current Free Cash Flow
of CureVac NV?

Discuss the annual earnings per share (EPS)
trend over the past five years for CureVac NV.

Wall Street Price Targets Revenue Forecast Operating Income Forecast Net Income Forecast See Also

Section:

Wall Street Price Targets

Revenue Forecast

Operating Income Forecast

Net Income Forecast

Wall Street
Price Targets

CVAC Price Targets Summary
CureVac NV

Wall Street analysts forecast CVAC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CVAC is 6.92 USD with a low forecast of 2.02 USD and a high forecast of 12.6 USD.

CVAC Average Forecast

Wall Street Target

6.92 USD

54% Upside

CVAC Highest Forecast

Wall Street Target

12.6 USD

181% Upside

Lowest

Price Target

2.02 USD

55% Downside

Average

Price Target

6.92 USD

54% Upside

Highest

Price Target

12.6 USD

181% Upside

CureVac NV Competitors:
Price Targets

4BB

4Basebio PLC

64% Upside

6990

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd

14% Downside

MRNA

Moderna Inc

73% Upside

AGIO

Agios Pharmaceuticals Inc

65% Upside

4BB

4Basebio PLC

64% Upside

6990

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd

14% Downside

MRNA

Moderna Inc

73% Upside

AGIO

Agios Pharmaceuticals Inc

65% Upside

IDYA

IDEAYA Biosciences Inc

137% Upside

002675

Yantai Dongcheng Biochemicals Co Ltd

0% Downside

QURE

Uniqure NV

124% Upside

ABBV

Abbvie Inc

14% Upside

Revenue
Forecast

Revenue Estimate
CureVac NV

For the last 5 years the compound annual growth rate for CureVac NV's revenue is 98%. The projected CAGR for the next 3 years is -36%.

98%

Past Growth

-36%

Estimated Growth

Estimates Accuracy

Average Beat

What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
CureVac NV

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-9%

Average Miss

What are analyst estimates?

Net Income
Forecast

Net Income Estimate
CureVac NV

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-5%

Average Miss

What are analyst estimates?

What is CVAC's stock price target?

Price Target
6.92 USD

According to Wall Street analysts, the average 1-year price target for CVAC is 6.92 USD with a low forecast of 2.02 USD and a high forecast of 12.6 USD.

What is CureVac NV's Revenue forecast?

Projected CAGR
-36%

For the last 5 years the compound annual growth rate for CureVac NV's revenue is 98%. The projected CAGR for the next 3 years is -36%.

	Franklin Covey Co NYSE:FC	23.135 USD 0.59%
	Mohawk Industries Inc NYSE:MHK	105.5347 USD 2.36%
	Ardmore Shipping Corp NYSE:ASC	9.65 USD 0.63%
	ASGN Inc NYSE:ASGN	55.495 USD 2.26%
	Skyworks Solutions Inc NASDAQ:SWKS	75.33 USD 2.95%
	Weatherford International PLC NASDAQ:WFRD	51.6475 USD 4.83%

	Johnson & Johnson NYSE:JNJ	156.67 USD 0.93%
	Bank of America Corp NYSE:BAC	45.075 USD 0.46%
	Mastercard Inc NYSE:MA	586.78 USD 0.42%
	Salesforce Inc NYSE:CRM	269.485 USD -1.02%
	Abbvie Inc NYSE:ABBV	189.905 USD 0.39%
	Home Depot Inc NYSE:HD	366.32 USD 0.31%

	Arista Networks Inc NYSE:ANET	93.54 USD -3.37%
	Deckers Outdoor Corp NYSE:DECK	110.09 USD -0.74%
	Visa Inc NYSE:V	368.5501 USD 0.52%
	Texas Pacific Land Corp NYSE:TPL	1 112.615 USD 0.69%
	KLA Corp NASDAQ:KLAC	847.025 USD 2.14%
	Manhattan Associates Inc NASDAQ:MANH	190.93 USD -1.4%

	Salesforce Inc NYSE:CRM	269.485 USD -1.02%
	Accenture PLC NYSE:ACN	320.06 USD 1.09%
	ServiceNow Inc NYSE:NOW	1 008.1 USD -1.83%
	Spotify Technology SA NYSE:SPOT	681.09 USD -2.58%
	EOG Resources Inc NYSE:EOG	118.97 USD 4.06%
	Applied Materials Inc NASDAQ:AMAT	173.46 USD 2.16%

CureVac NV
NASDAQ:CVAC